A Study Analyzing Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma
Latest Information Update: 11 Mar 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 11 Mar 2022 New trial record
- 08 Mar 2022 Results published in the Journal of Clinical Oncology